Supplement shows promise for kidney Patients' heart health
NCT ID NCT04040959
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a natural supplement called nicotinamide riboside can improve artery stiffness and lower blood pressure in people with moderate to severe chronic kidney disease. About 118 adults aged 35-80 will take either the supplement or a placebo for 3 months. The goal is to see if this approach can reduce heart disease risk in this high-risk group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UColorado
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your bone health decide if a dental implant lasts?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple blood test flag heart risk in rheumatoid arthritis?
- Can a simple foot pump ease leg swelling in hospital patients?
- Could a phone app help parents of kids with special needs thrive?
- Could your blood type predict kidney treatment success?